Recent coverage of our peer-reviewed research, in the healthcare and mainstream press.
Several outlets covered a study by The Dartmouth Institute for Health Policy and Clinical Practice, which appears in the May issue of The American Journal of Managed Care (AJMC). As Emily Rappleye reported in Becker’s Hospital Review, researchers gauging physician awareness of the Choosing Wisely campaign found that while 92% felt a responsibility to control medical costs, only 37% felt they understood how much tests and procedures should cost. For the full study, led by Carrie H. Colla, PhD, click here.
A 2011 AJMC study led by William Boulding, PhD, which found that patient perception of care is an important predictor of 30-day readmission, was featured in the update, “The Patient Experience: Does This Really Matter?” in Health Leaders. Dan Smith, MD, FACEP, medical director of the Studer Group, discussed how providers who make patient experience a priority will stand out as transparency and accountability become more important. For the original AJMC study, click here.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More